Small-Molecule Modulators for Selective Melanin Induction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current agents are inadequate in effectively inducing melanin production in melanocytes to protect against ultraviolet light and reduce the incidence of skin cancer, as they often fail to stimulate melanin synthesis without increasing cellular proliferation.

Innovation Solution

Development of novel compounds formed by reacting specific carboxylic acids and amines, which are capable of inducing melanin expression in melanocytes, thereby increasing skin pigmentation without promoting cellular proliferation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If current agents are used to induce melanin production, then melanin synthesis is stimulated, but cellular proliferation increases causing adverse effects

Engineering Contradiction:
Improvemelanin productionVSAvoidcellular proliferation
Core Design Contradiction:
Quantity of substanceVSObject-generated harmful factors

Solution Approach 1:

The patent modifies chemical parameters by developing novel compounds with specific molecular structures (combining carboxylic acid and amine components with defined chemical formulas) that selectively induce melanin production without triggering cellular proliferation, thereby resolving the contradiction between effective melanin synthesis and harmful cell growth

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention achieves selective action by designing compounds that target specific melanogenic pathways in melanocytes while leaving other cellular processes unaffected. The compounds specifically stimulate melanin synthesis enzymes (tyrosinase, TRP-1, TRP-2) without activating general cell proliferation mechanisms, creating localized beneficial effects without systemic adverse responses

Inventive Principle:
Principle #3Local quality

2Reliability

If melanin production is increased to protect against UV radiation, then skin cancer risk is reduced, but current agents lack sufficient effectiveness

Engineering Contradiction:
Improveprotection against skin cancerVSAvoidmelanin synthesis efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent employs composite molecular structures combining specific carboxylic acid components (with aromatic rings, carbonyl groups) and amine components (with heterocyclic structures, basic nitrogen atoms) to create compounds with enhanced and synergistic melanin-inducing activity, achieving superior effectiveness compared to single-component agents

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The novel compounds act as intermediaries that bridge the gap between UV protection needs and efficient melanin synthesis. They mediate the signaling pathways between melanocyte stimulation and melanin production, effectively translating protective intent into actual melanin synthesis without requiring excessive cellular activation

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS9162984B2Small-molecule modulators of melanin expression
Publication Date: 2015.10.20 UNIVERSITY OF ROCHESTER
  • US9162984B2 patent drawing
  • US9162984B2 patent drawing
  • US9162984B2 patent drawing

AI summary

The present invention relates to small molecule modulators of melanin expression and methods of making the small molecules. Also disclosed are methods of increasing pigmentation in a cell which involve providing compounds of the present invention and contacting a cell with the compounds under conditions effective to induce melanin expression in the cell, thereby increasing pigmentation. The present invention also relates to compositions containing compounds of the present invention and a carrier.